What is this medicine used for?
FDA-approved uses
- Moderate-to-severe Alzheimer’s dementia — Adults. Symptomatic treatment; no evidence that it prevents or slows neurodegeneration.Memantine immediate-release tablets; Memantine extended-release capsules.
What should I expect?
Treatment may help cognition and everyday functioning, but benefit varies and may be modest. Memantine has not been shown to stop or reverse the underlying disease.
The dose is usually increased gradually over several weeks. A caregiver can help track daily abilities, constipation, dizziness and falls; review benefit and tolerability at follow-up rather than expecting immediate memory restoration.
How do I take it safely?
Take with or without food according to the prescribed IR or ER schedule. ER capsules may be swallowed whole or opened onto applesauce; swallow the entire contents without chewing. Do not crush, divide or chew the ER dose.
Kidney function determines whether a lower dose is needed. Review severe liver disease, seizures, urinary problems or severe urinary infection with the clinician.
Have sodium bicarbonate, medicines that change urine acidity, amantadine, ketamine and dextromethorphan-containing cough medicines reviewed. Limited liver metabolism does not mean there are no interactions.
Follow cognition, daily activities, bowel symptoms, dizziness and falls. Caregiver or pharmacy support can help prevent duplicate doses or confusion between IR and ER products.
Skip a single missed dose and take the next on schedule. Never double. After several missed days, contact the prescriber because a lower restart dose and retitration may be needed.
Plan stopping or changing products with the treating team. A memantine/donepezil combination adds a second medicine’s precautions. Pregnancy, breastfeeding and pediatric safety are not established.
Do not use after a known memantine or ingredient allergy.
What side effects should I know about?
- Dizziness, headache, confusion and constipation with immediate-release treatment.
- Headache, diarrhea and dizziness with extended-release treatment.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Memantine immediate-release tablets: current generic prescribing information
- View FDA Prescribing Information (PDF) (opens in a new tab)Memantine ER capsules: current generic prescribing information
Which warning signs need help?
- Contact the clinician promptly for severe new confusion, hallucinationsHallucinationsA hallucination is a sensory experience without a corresponding external source—for example, hearing a voice when nobody is speaking. It can involve hearing, sight, touch, smell or taste and may feel very real.A hallucination is an experience; a delusion is a belief. Hallucinations can have different causes, so an assessment is needed to understand them., marked sleepiness, unsteadiness or repeated falls.
- Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.
What else should I know to stay safe?
- Do not use after memantine or ingredient allergy. Severe kidney impairment requires a lower dose; review severe liver disease, seizures, urinary problems and severe urinary infection. Monitor daily functioning, dizziness, constipation and falls.
- Have sodium bicarbonate, medicines that change urine acidity, amantadine, ketamine and dextromethorphan-containing cough medicines checked. A memantine/donepezil combination adds a second medicine’s precautions.
- After several days without treatment, ask before restarting because a lower dose and retitration may be needed. Plan stopping or switching with the treating team. Pregnancy, breastfeeding and pediatric safety are not established.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- The IR and ER numbers are different for a reason: they are distinct regimens, not a simple milligram-for-milligram exchange.
- Kidney function can matter more than age alone when choosing the dose.
- Some cough medicines and even products that change urine acidity can interact. Include nonprescription products in the medication list.
How does it work?
Memantine changes the activity of NMDA receptors, receiving proteins that respond to glutamate, a chemical messenger used by brain cells. These receptors control tiny channels through which electrically charged particles can move. Memantine can block an open channel, an action thought to contribute to symptom benefit, although the full explanation remains uncertain.
Explore more in Brain & Science: NMDA Receptors: Memantine.
How was this medicine developed?
Namenda tablets received FDA approval in 2003, and Namenda XR followed in 2010. Memantine offered a different approach from medicines that prevent acetylcholine breakdown, while remaining a treatment for symptoms rather than a cure.
How do I say the name?
Memantine: MEM-an-teen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
- Memantine immediate-release tablets
- Memantine extended-release capsules
- Memantine oral solution
- Memantine with donepezil
Memantine immediate-release tablets
Starts once daily, maintenance in divided doses; separate severe-kidney limit.
Memantine extended-release capsules
Once daily; do not crush, chew or divide the capsule contents.
Memantine oral solution
Measuring and handling instructions need product-specific review.
Memantine with donepezil
Separate two-ingredient product; Namzaric search remains assigned to the existing donepezil identity with an outside-scope warning.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Memantine immediate-release tablets: current generic prescribing information
- Memantine ER capsules: current generic prescribing information
- Namenda tablets: FDA approval and discontinued brand status
- Memantine: patient information and historical brands
- Namenda XR: FDA approval and discontinued brand status
- Namenda immediate-release tablets: FDA prescribing information
- Memantine: Package Insert / Prescribing Information / MOA
- Namenda XR: FDA prescribing information
- Galantamine: current prescribing information
- Memantine: verified neutral parent, PubChem CID 4054
- ISMP List of Confused Drug Names
- Schizophrenia
- NIMH: Understanding psychosis
Giving medicine safely to children: family guide (PDF, 3 pages)

